Abattis Bioceuticals Corp. (ATTBF)

[guay]

ATTBF to Be Available in S&P Capital IQ Market Access Program
NEW YORK, March 25, 2015 /PRNewswire/
S&P Capital IQ (MHFI) announced today that it has commenced Factual Stock Report coverage on Abattis Bioceuticals Corp.
Abattis Bioceuticals (OTCQX: ATTBF; CSE: ATT): is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America. The company seeks to capitalize on the current trend toward marijuana legalization in the United States and for medicinal use in Canada and international jurisdictions, by supplying and partnering with companies to employ its mass cultivation systems, extraction equipment/technology, and strategic marketing support to licensed growers. Abattis also has an extensive pipeline of products and intellectual property for the botanical drug market.
http://otc.club/marijuana-stocks/sp-capital-iq-initiates-coverage-on-abattis-bioceuticals-corp-in-sp-capital-iq-factual-stock-reports/